You just read:

Amyvid™ (Florbetapir F 18 Injection) Approved in European Union for Use in Patients With Cognitive Impairment Being Evaluated for Alzheimer's Disease and Other Causes of Cognitive Impairment

News provided by

Eli Lilly and Company

Jan 15, 2013, 03:36 EST